Diester type catechin compound and preparation method thereof

Through ultrasonic extraction and multi-step reverse phase liquid chromatography separation technology, the problem of single extraction and preparation methods of catechin compounds was solved, and high-purity diester-type catechin compounds were successfully obtained, filling the research gap, and making tea leaves Research and industry applications provide the basis.

CN118908929AActive Publication Date: 2024-11-08TEA RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202410801575.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-20
Publication Date
2024-11-08
Estimated Expiration
2044-06-20

AI Technical Summary

Technical Problem

In the prior art, the extraction and preparation methods of catechin compounds are relatively single, and the thermal instability of diester-type catechin compounds increases the difficulty of research, resulting in fewer research reports.

Method used

Ultrasonic extraction combined with multi-step reverse phase liquid chromatography separation and reduced pressure lyophilization technology was used to extract and separate diester-type catechins from tea. Unreported chromatography and gradient elution conditions were obtained. The novel compound epigallocatechin-3,4'-di-O-gallate and the first purified monomeric compound gallocatechin-3,4'-di-O-gallate.

Benefits of technology

High purity extraction of diester-type catechin compounds has been achieved, providing the basis for the research of tea ingredients and application of beverage and food industry, and providing support for tea quality control and commercial development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118908929A_ABST
    Figure CN118908929A_ABST
Patent Text Reader

Abstract

The preparation method comprises the following steps: mixing tea leaves with a methanol aqueous solution, and carrying out ultrasonic extraction to obtain a tea leaf extracting solution; according to the present invention, the tea leaf extraction liquid is continuously subjected to reversed-phase liquid chromatography separation, the diester type catechin compound is finally obtained by collecting the specific eluent and the fractions in the specific time period, the diester type catechin compound is obtained through the preparation method, the diester type catechin compound is obtained through separation and purification for the first time, and the purity of the diester type catechin compound is high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of compound extraction and preparation, and specifically relates to a diester type catechin compound and a preparation method thereof. Background Art

[0002] Catechins are a class of polyphenol compounds widely found in plants, with a 2-phenylbenzopyran skeleton structure. Catechins are the most abundant substances in tea leaves, accounting for 12-14% of the dry weight of tea leaves.

[0003] During the secondary metabolism of plants, catechins will form various catechin monomers, such as catechin (C), epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG), epigallocatechin gallate (EGCG), etc. These catechin compounds also show various biological activities including antioxidant, anti-tumor, anti-inflammatory, antibacterial, and antiviral. Hydroxylation and esterification are reactions that are prone to occur on the skeleton of catechins. In addition to the changes in the number of reactions and the reaction sites that produce isomers, catechins can also form polymers with different degrees of polymerization, such as dimers and trimers. Therefore, the forms of catechins in tea are diverse, but the structures of these compounds are also unstable. Under the action of external heating, catechins will undergo oxidative degradation or isomerization and transform into their corresponding stereoisomers.

[0004] Since catechin compounds have similar structures and complex stereochemical properties, the thermal instability of diester catechin compounds is more prominent, which increases the difficulty of material basis research. The types of catechin compounds purified from tea leaves are relatively fixed, with relatively few research reports and relatively simple extraction and preparation methods. Summary of the invention

[0005] In view of the problems existing in the prior art, the purpose of the present invention is to provide a diester type catechin compound and a preparation method thereof. This is specifically achieved through the following technical solutions:

[0006] 1) mixing tea leaves with methanol aqueous solution, performing ultrasonic extraction, and filtering to obtain tea leaf extract;

[0007] 2) Under room temperature, the tea extract is separated by reverse phase liquid chromatography through a packed column filled with fillers, and the 15min-20min fraction is collected to obtain a first fraction, wherein 0.05% trifluoroacetic acid aqueous solution is used as mobile phase A, and methanol is used as mobile phase B; the mobile phase gradient elution mode is 0min-10min, 8%-15% mobile phase B; 10min-40min, 15%-25% mobile phase B; 40min-45min, 25%-100% mobile phase B; 45min-60min, 100% mobile phase B; the flow rate is 80mL / min, and the injection volume is 125mL; the filler is an octadecyl bonded stationary phase;

[0008] The first fraction was placed in a refrigerator for pre-freezing for 3 h to 5 h, and then transferred to a vacuum freeze dryer for lyophilization under reduced pressure to remove the solvent to obtain a crude sample component;

[0009] 3) Under room temperature, the crude component of the sample is separated by reverse phase liquid chromatography through a packed column filled with filler, and the fractions are collected according to the chromatographic peak type of the fraction liquid phase preparation spectrum, and the elution chromatographic peak of 19min-21.5min is collected to obtain a second fraction, wherein 0.05% trifluoroacetic acid aqueous solution is used as mobile phase A, and acetonitrile is used as mobile phase B; the mobile phase gradient elution mode is 0min-25min, 15%-30% mobile phase B; 25min-30min, 30%-95% mobile phase B; 30min-40min, 95% mobile phase B; the flow rate is 80mL / min, and the injection volume is 20mL; the filler is an octadecyl bonded stationary phase;

[0010] The second fraction was placed in a refrigerator for pre-freezing for 3 h to 5 h, and then transferred to a vacuum freeze dryer for lyophilization under reduced pressure to remove the solvent, thereby obtaining a fine fraction of catechins;

[0011] 4) Under room temperature, the catechin fine components are separated by reverse phase liquid chromatography through a packed column filled with fillers, and the fractions are collected according to the chromatographic peak type of the fraction liquid phase preparation spectrum, and the elution chromatographic peaks of 27min-30min and 37min-39min are collected to obtain the third fraction and the fourth fraction correspondingly, wherein 0.05% trifluoroacetic acid aqueous solution is used as mobile phase A, and methanol is used as mobile phase B; the mobile phase gradient elution mode is 0min-20min, 25% mobile phase B; 20min-30min, 25%-35% mobile phase B; 30min-45min, 35% mobile phase B; the flow rate is 80mL / min, and the injection volume is 80mL; the filler is a mixture of octadecyl bonded stationary phase filler and isopropanol;

[0012] The third fraction and the fourth fraction are respectively placed in a refrigerator for pre-freezing for 3h-5h, transferred to a vacuum freeze dryer, and freeze-dried under reduced pressure to remove the solvent to obtain a diester catechin compound; the diester catechin compound is epigallocatechin-3,4'-di-O-gallate or gallocatechin-3,4'-di-O-gallate.

[0013] Preferably, the tea leaves are green tea, yellow tea, black tea, dark tea, white tea or oolong tea.

[0014] Preferably, the concentration of the methanol-water solution during ultrasonic extraction of tea leaves is 12%-15%.

[0015] Preferably, the mass volume ratio of the tea leaves and the methanol aqueous solution is 1g:40-60L.

[0016] Preferably, the ultrasonic extraction time is 20 min-30 min, and after the ultrasonic extraction, the filtrate is filtered and retained, and then filtered through a filter membrane to obtain a tea extract.

[0017] Preferably, the pore size of the filter membrane is 0.45 μm-0.5 μm.

[0018] Preferably, the column bed height of the packed column is 260 mm and the diameter is 50 mm.

[0019] Preferably, the temperature inside the refrigerator and the temperature inside the vacuum freeze dryer are both set to -80°C.

[0020] The diester type catechin compound prepared by the above preparation method has the following structural characteristics:

[0021]

[0022] The present invention uses ultrasonic extraction of tea leaves combined with multi-step continuous reversed phase liquid chromatography separation and purification, and vacuum freeze-drying technology, and uses specific chromatography and gradient elution conditions to extract an unreported new compound 1 from tea leaves.

[0023] (epigallocatechin-3,4'-di-O-gallate) and the monomer compound 3 (gallocatechin-3,4'-di-O-gallate) obtained for the first time by separation and purification, the obtained diester type catechin compound has high purity, and the preparation method can be applied in tea component research and beverage and food industry or biopharmaceutical industry, providing a certain material basis for the quality control and commercial development of tea. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1It is a reverse phase preparative chromatography crude separation of tea extract;

[0025] Figure 2 is the reverse phase liquid preparation spectrum of fraction F1;

[0026] Figure 3 is the reverse phase liquid preparation spectrum of fraction F1-1;

[0027] Figure 4 It is the primary negative ion mode spectrum of compound 1 in ultra-high performance liquid chromatography-high resolution mass spectrometry;

[0028] Figure 5 It is the secondary negative ion mode spectrum of compound 1 in ultra-high performance liquid chromatography-high resolution mass spectrometry;

[0029] Figure 6 is compound 1 1 H NMR spectrum;

[0030] Figure 7 is compound 1 13 C NMR spectrum;

[0031] Figure 8 is compound 1 1 H- 1 H COSY spectrum;

[0032] Fig. 9 is the HSQC spectrum of compound 1;

[0033] Fig.10 is the HMBC spectrum of compound 1. DETAILED DESCRIPTION

[0034] The present invention is further described below in conjunction with the accompanying drawings in order to better understand the technical solution.

[0035] Example

[0036] 20 g of green tea leaves were mixed with 1 L of 15% methanol aqueous solution, and ultrasonic extraction was performed for 30 min. The filtrate was filtered and filtered through a 0.46 μm pore size filter membrane to obtain a tea extract.

[0037] At room temperature, the tea extract was separated by reverse phase liquid chromatography through a packed column filled with fillers, and the sample liquid phase was prepared according to the spectrum (such as Figure 1The first fraction is obtained by collecting fractions at a retention time of 15 min to 20 min, and the fraction is marked as fraction F1, wherein, in the reversed phase liquid chromatography separation process, 0.05% trifluoroacetic acid aqueous solution is used as mobile phase A, and methanol is used as mobile phase B; the mobile phase gradient elution mode is: 0 min to 10 min, the volume of mobile phase B is 8% to 15%, and the volume of mobile phase A is 85% to 92%; 10 min to 40 min, the volume of mobile phase B is 15% to 25%, and the volume of mobile phase A is 75% to 85%; 40 min to 45 min, the volume of mobile phase B is 25% to 100%, and the volume of mobile phase A is 0 to 75%; 45 min to 60 min, the volume of mobile phase B is 100%; the flow rate is 80 mL / min, and the injection volume is 125 mL; the filler is 320 g of octadecyl bonded stationary phase;

[0038] Fraction F1 was pre-frozen in a -80°C refrigerator for 4 h, transferred to a vacuum freeze dryer, the freezing temperature was set to -80°C, and the solvent was removed by lyophilization under reduced pressure to obtain a crude sample component;

[0039] At room temperature, the crude sample components were separated by reverse phase liquid chromatography through a packed column filled with fillers. Figure 2 The fractions were collected according to the chromatographic peak type shown in the figure, and the elution chromatographic peak of 19min-21.5min was collected to obtain the second fraction, which was marked as fraction F1-1, wherein, in the reversed phase liquid chromatography separation process, 0.05% trifluoroacetic acid aqueous solution was used as mobile phase A, and acetonitrile was used as mobile phase B; the mobile phase gradient elution mode was 0min-25min, the volume of mobile phase B was 15%-30%, and the rest was mobile phase A; 25min-30min, the volume of mobile phase B was 30%-95%, and the rest was mobile phase A; 30min-40min, the volume of mobile phase B was 95%, and the rest was mobile phase A; the flow rate was 80mL / min, and the injection volume was 20mL; the filler was 320g octadecyl bonded stationary phase;

[0040] The fraction F1-1 was pre-frozen in a -80°C refrigerator for 4 h, transferred to a vacuum freeze dryer, the freezing temperature was set to -80°C, and the solvent was removed by lyophilization under reduced pressure to obtain a fine fraction of catechins;

[0041] At room temperature, the catechin fine components are separated by reverse phase liquid chromatography through a packed column filled with fillers, and the fraction liquid phase spectrum (such as Figure 3The fractions were collected according to the chromatographic peak type (shown in the figure), and the elution chromatographic peaks at 27min-30min, 32min-36min and 37min-39min were collected respectively, and the third fraction, the fifth fraction and the fourth fraction were obtained respectively, and they were marked as fraction F1-1-1, fraction F1-1-2 and fraction F1-1-3, wherein 0.05% trifluoroacetic acid aqueous solution was used as mobile phase A, and methanol was used as mobile phase B; the mobile phase gradient elution mode was 0min-20min, the volume of mobile phase B was 25%, and the volume of mobile phase A was 75%; 20min-30min, the volume of mobile phase B was 25%-35%, and the rest was mobile phase A; 30min-45min, the volume of mobile phase B was 35%, and the volume of mobile phase A was 65%; the flow rate was 80mL / min, and the injection volume was 80mL; the filler was 320g octadecyl bonded stationary phase filler;

[0042] Fraction F1-1-1 and fraction F1-1-3 were pre-frozen in a -80°C refrigerator for 4 hours, respectively, and transferred to a vacuum freeze dryer, the freezing temperature was set to -80°C, and the solvent was removed by reduced pressure freeze drying to obtain diester-type catechin compounds;

[0043] The fraction F1-1-2 was pre-frozen in a -80°C refrigerator for 4 h, transferred to a vacuum freeze dryer, the freezing temperature was set to -80°C, and the solvent was removed by lyophilization under reduced pressure to obtain a monoester catechin compound;

[0044] Among them, the diester-type catechin compound obtained by lyophilizing fraction F1-1-1 under reduced pressure is epigallocatechin-3,4'-di-O-gallate (off-white powder, purity 93.2%, mass 18.6 mg, recorded as compound 1).

[0045] The diester-type catechin compound obtained by freeze-drying fraction F1-1-3 under reduced pressure was gallocatechin-3,4'-di-O-gallate (off-white powder, purity 95.7%, mass 12.1 mg, recorded as compound 3). The monoester-type catechin compound obtained by freeze-drying fraction F1-1-2 was epicatechin-3-O-gallate (white powder, purity 94.9%, mass 40.2 mg, recorded as compound 2).

[0046] In this embodiment, the tea leaves may be yellow tea, black tea, dark tea, white tea or oolong tea.

[0047] Regarding the structural identification test of compound 1: 1 H NMR, 13C NMR, two-dimensional nuclear magnetic resonance spectroscopy and ultra-high performance liquid chromatography tandem high-resolution mass spectrometry were used to identify the structure of compound 1 prepared according to the preparation method of the present application. The specific results are as follows: Figure 4-Figure 10 shown.

[0048] Depend on Figure 4 and Figure 5 It can be seen that HR-ESI-MS negative ion mode [MH] + m / z=609.0886, molecular formula is C 29 H 22 O 15 , the secondary negative ion mode fragments mainly include m / z=457.0769, 305.0661, and 169.0410.

[0049] Combination 1 H NMR spectrum ( Figure 6 ), 13 C NMR ( Figure 7 ), 1 H- 1 H COSY spectrum ( Figure 8 )、HSQC spectrum( Fig. 9 ) and HMBC spectra ( Fig.10 ), and analyzed each detection spectrum to determine that compound 1 is epigallocatechin-3,4'-di-O-gallate. The NMR signals of compound 1 are as follows:

[0050] 1 H NMR (600 MHz, DMSO-d 6 )δ:9.55(2H,s,3',5'-O H ),9.46(1H,5-O H ),9.42(s,1H),9.42(2H,s,3”,5”-O H ),9.34(2H,s,3”',5”'-O H ),9.22(1H,s,7-O H ),7.07(2H,s,H-2”,6”),6.90(2H,s,H-2”’,6”’),6.62(2H,s,H-2’,6’),5.99(1H,d,J 6,8 =2.5Hz,H-6),5.87(1H,d,J 8,6 =2.1Hz,H-8),5.34(1H,d,J 3,4 =3.6Hz,H-3),5.05(1H,s,H-2),2.95(1H,m,H-4α),2.72(1H,d,J 4α,β=16.4Hz,H-4β).

[0051] 13 C NMR (150 MHz, DMSO-d 6 )δ:165.86(C-10, C O),164.31(C-9, C O),157.10(C-5),156.98(C-7),155.75(C-8a),150.37(C-3',C-5'),146.03,145.92 (C-3”,5”,3”’,5”’),139.05,139.00(C-4”,4”’),136.26(C-1’),126.77(C-4’),119. 66,119.49(C-1”,1”’),109.75(C-2”,C-6”),109.20(C-2”’,C-6”’),105.89(C-2’,C -6'),97.64(C-4a),96.17(C-6),94.76(C-8),76.78(C-2),68.66(C-3),25.99(C-4).

[0052] Regarding the structural identification test of the above compound 2: 1 H NMR, 13 C NMR was used to identify the structure of compound 2. Compound 2 is epicatechin-3-O-gallate. The NMR signals of compound 2 are assigned as follows:

[0053] 1 H NMR (600 MHz, DMSO-d 6 )δ8.81-9.34(7H,-O H ),6.88(1H,d,J 2’,6’ =1.9Hz,H-2”),6.83(2H,s,H-2',6'),6.75(1H,dd,J 6’,5’ =8.2,J 6’,2’ =1.8Hz,H-6”),6.66(1H,d,J 5’,6’ =8.1Hz,H-5”),5.95(1H,d,J 6,8 =2.2Hz,H-6),5.84(1H,d,J 8,6 =2.2Hz,H-8),5.34(1H,dt,J 3,4 =4.3Hz,J 3,2 =1.9Hz,H-3),5.03(1H,s,H-2),2.68-2.94(2H,m,H-4).

[0054] 13 C NMR (150 MHz, DMSO-d 6 )δ165.65(C-9),157.02(C-5),156.95(C-7),156.07(C-8a),145.89(C-3 ",5"),145.20(C-3',4'),139.01(C-4"),129.84(C-1'),119.66(C-5'), 118.01(C-1”),115.54(C-6’),114.73(C-2’),109.06(C-2”,6”),97.71( C-4a),96.00(C-6),94.80(C-8),76.93(C-2),68.62(C-3),26.11(C-4).

[0055] Regarding the structural identification test of the above compound 3: 1 H NMR, 13 C NMR was used to identify the structure of compound 3. The NMR signals of compound 3 were assigned as follows:

[0056] 1 H NMR (600 MHz, DMSO-d 6 )δ9.49(s,2H 3',5'-O H ),9.39(d,J=10.6Hz,2H),9.28(s,2H),9.16(d,J=8.0Hz,1H),7.06(s,2H),6.87(s,2H),6.58(s,2H),5.97( t,J=2.3Hz,1H),5.87(d,J=2.4Hz,1H),5.38(s,1H),5.07(d,J=2.7Hz,1H),3.03–2.89(m,1H),2.71(1H,d,J 4α,β =15.8Hz,H-4β).

[0057] 13 C NMR (150 MHz, DMSO-d 6 )δ:163.67(C-10, C O),162.20(C-9, CO),154.97(C-5),154.86(C-7),153.69(C-8a),148.24(C-3',C-5'),143.90,143. 79(C-3”,5”,3”’,5”’),136.97,136.94(C-4”,4”’),134.18(C-1’),124.71(C-4’), 117.55(C-1”,1”’),107.61(C-2”,C-6”),107.06(C-2”’,C-6”’),103.77(C-2’,C-6 '),95.61(C-4a),94.02(C-6),92.65(C-8),74.62(C-2),66.35(C-3),23.96(C-4).

[0058] By analyzing the structures of compound 1 and compound 3, it can be seen that the compounds prepared by the preparation method of the present invention have the following common structural features:

[0059]

[0060] Among them, the compound 1 prepared by the preparation method is a catechin compound that has not been reported and discovered. The configuration and substituents of the compound 1 are 2R, 3R, R 1 =G,R 2 =R 3 =R 4 =H,R 5 =OH; the monomer compound 3 obtained by separation and purification for the first time has the following configuration and substituents:

[0061] 2R,3S,R 1 =G,R 2 =R 3 =R 4 =H,R 5 =OH, wherein the substituent G is:

[0062]

Claims

1. A method for preparing a diester type catechin compound, characterized in that: The following steps are involved: 1) mixing tea leaves with methanol aqueous solution, performing ultrasonic extraction, and filtering to obtain tea leaf extract; 2) Under room temperature, subjecting the tea extract of step 1) to reverse phase liquid chromatography separation, collecting the 15-20 min fraction to obtain a first fraction; pre-freezing the first fraction in a refrigerator for 3 h to 5 h, transferring it to a vacuum freeze dryer, and performing reduced pressure freeze drying to remove the solvent to obtain a crude sample component; Chromatographic separation conditions: 0.05% trifluoroacetic acid aqueous solution as mobile phase A, methanol as mobile phase B; mobile phase gradient elution mode: 0min-10min, 8%-15% mobile phase B; 10min-40min, 15%-25% mobile phase B; 40min-45min, 25%-100% mobile phase B; 45min-60min, 100% mobile phase B; flow rate: 80mL / min, injection volume: 125mL; filler: octadecyl bonded stationary phase; 3) Under room temperature, the crude fraction of the sample is separated by reverse phase liquid chromatography, and the fractions are collected according to the chromatographic peak type of the fraction liquid phase preparation spectrum, and the elution chromatographic peak of 19min-21.5min is collected to obtain the second fraction; the second fraction is placed in a refrigerator for pre-freezing for 3h-5h, transferred to a vacuum freeze dryer, and the solvent is removed by reduced pressure freeze drying to obtain a fine fraction of catechins; Chromatographic separation conditions: 0.05% trifluoroacetic acid aqueous solution as mobile phase A, acetonitrile as mobile phase B; mobile phase gradient elution mode: 0min-25min, 15%-30% mobile phase B; 25min-30min, 30%-95% mobile phase B; 30min-40min, 95% mobile phase B; flow rate: 80mL / min, injection volume: 20mL; filler: octadecyl bonded stationary phase; 4) Under room temperature, the fine components of catechins are separated by reverse phase liquid chromatography, and fractions are collected according to the chromatographic peak type of the fraction liquid phase preparation spectrum, and the elution chromatographic peaks of 27min-30min and 37min-39min are collected to obtain the third fraction and the fourth fraction respectively; the third fraction and the fourth fraction are respectively placed in a refrigerator for pre-freezing for 3h-5h, transferred to a vacuum freeze dryer, and lyophilized under reduced pressure to remove the solvent to obtain diester type catechin compounds; the diester type catechin compounds are epigallocatechin-3,4'-di-O-gallate and gallocatechin-3,4'-di-O-gallate; Chromatographic separation conditions: 0.05% trifluoroacetic acid aqueous solution as mobile phase A, methanol as mobile phase B; mobile phase gradient elution mode: 0min-20min, 25% mobile phase B; 20min-30min, 25%-35% mobile phase B; 30min-45min, 35% mobile phase B; flow rate is 80mL / min, injection volume is 80mL; the filler is octadecyl bonded stationary phase.

2. The method for preparing a diester type catechin compound according to claim 1, characterized in that In step 1), the concentration of methanol water is 12-15%, and the mass volume ratio of tea leaves to methanol water is 1g:40-60L.

3. The method for preparing a diester type catechin compound according to claim 1, characterized in that The ultrasonic extraction time in step 1) is 20-30 minutes. After the ultrasonic extraction, the filtrate is filtered and retained. The filtrate is filtered through a filter membrane to obtain a tea extract.

4. The method for preparing a diester type catechin compound according to claim 3, characterized in that The pore size of the filter membrane in step 1) is 0.45 μm-0.5 μm.

5. The method for preparing a diester type catechin compound according to claim 1, characterized in that The column used for chromatographic separation has a height of 260 mm and a diameter of 50 mm.

6. The method for preparing a diester type catechin compound according to claim 1, characterized in that The pre-freezing temperature of the refrigerator and the temperature inside the vacuum freeze dryer were both set at -80°C.

7. A diester type catechin compound prepared by the preparation method according to any one of claims 1 to 6, wherein the diester type catechin compound has the following structural characteristics:

Citation Information

Patent Citations

  • Method for purifying epigallo catechin gallate (EGCG)

    CN102276570A

  • Method for preparing high-purity gallnut catechin gallate (GCG)

    CN105601606A

  • Method used for preparing three kinds of polyester type catechin monomers

    CN109879850A